Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06819670
PHASE2

A Study to Prevent Infantile Spasms Relapse

Sponsor: University of California, Los Angeles

View on ClinicalTrials.gov

Summary

After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.

Official title: A Multicenter Pilot Clinical Trial to Prevent Infantile Spasms Relapse

Key Details

Gender

All

Age Range

2 Months - 18 Months

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-05-05

Completion Date

2028-06-30

Last Updated

2025-05-08

Healthy Volunteers

No

Interventions

DRUG

Prednisolone

active drug

DRUG

Famotidine

active drug

DRUG

Placebo

non-active drug

Locations (1)

UCLA

Los Angeles, California, United States